Skip to main content

Efectos de la dieta y la ingesta accidental de nanoplasticos sobre el epigenoma

RYC2022-037626-I

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprogram Subprograma Estatal de Incorporación
Call Ramón y Cajal
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION IMDEA NUTRICIÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cocoa–carob blend acute intake modifies miRNAs related to insulin sensitivity in type 2 diabetic subjects: a randomised controlled nutritional trial

  • Villalva, Marisol
  • García-Díez, Esther
  • López de las Hazas, María-Carmen
  • Iacono, Oreste Lo
  • Vicente-Díez, Ignacio
  • García-Cabrera, Sara
  • Alonso-Bernáldez, Marta
  • Dávalos, Alberto
  • Martín, M. Ángeles
  • Ramos, Sonia
  • Pérez-Jiménez, Jara
Postprandial metabolic disturbances are exacerbated in type 2 diabetes (T2D). Cocoa and carob, despite showing promising effects on these alterations in preclinical studies, have not yet been jointly tested in a clinical trial. Therefore, this acute, randomised, controlled, crossover nutritional trial evaluated the postprandial effects of a cocoa-carob blend (CCB) in participants with T2D (n = 20) and overweight/obesity. The subjects followed three treatments: hypercaloric breakfast (high-sugar and high-saturated fat, 900 kcal) as the control (treatment C); the same breakfast together with 10 g of the CCB, with 5.6 g of dietary fibre and 1.6 g of total polyphenols (treatment A); and the same breakfast after consuming the CCB (10 g) the night before (treatment B). Various analyses were performed, including the determination of the clinical markers of T2D (fasting and postprandial glucose and insulin, GLP-1, and glycaemic profile), satiety evaluation, analysis of exosomal miRNA expression and ex vivo determination of inflammation modulation. No effect on glucose homeostasis (glucose, insulin, and GLP-1) was found in the study population. However, eight exosomal miRNAs were found to be significantly modified owing to CCB supplementation compared with treatment C, with three of them (miR-20A-5p, miR-23A-3p, and miR-17-5p) associated with an improvement in insulin sensitivity. Furthermore, the CCB caused a decrease in hunger feelings (0-120 min), as assessed by the visual analogue scale (VAS). Finally, treatment A caused a significant decrease in the glucose increment within 0-30 min of treatment in subjects with overweight. No significant modifications were found in the other assessed parameters. The acute intake of the CCB by subjects with T2D showed modest although significant results, which need to be validated in a long-term randomised controlled trial., This work was supported by the grant RTI2018-095059-B-I00, funded by MCIN/AEI/10.13039/501100011033/ and “ERDF A way of making Europe”. The study was partially funded by TED2021-130962B-C21 and financed by MICIU/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR. None of the funders were involved in the assessment and interpretation of the data or in manuscript preparation. E. G.-D. was the recipient of a contract from Comunidad de Madrid (PEJ-2020-AI/BIO-18529). M. V. was the recipient of a postdoctoral contract “Margarita Salas” (Plan de Recuperación, Transformación y Resiliencia) from the Spanish Ministry of Universities and Madrid Autonomous University (CA1/RSUE/2021-00588). MCLH is a recipient of of a Ramon y Cajal Grant RYC2022-037626-I, MCIU/AEI/10.13039/501100011033 and FSE+. CIBEROBN (CB22/03/00068) and CIBERDEM (CB/07/08/0013) are initiatives of the Instituto de Salud Carlos III, Spain. Ms M. Nogués Cañadas, Mr I. Escudero Abad and Ms. M. Renard are thanked for technical assistance. Ms Macarena Paredes-López, from Siemens, provided technical support during abdominal echographia and transient elastography assessments., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Hydroxytyrosol Enhances Plasma Extracellular Vesicle Secretion, Modulates Their miRNAs Cargo, and Reduces LDL Oxidation in Humans: Postprandial and 1-Week Effects

  • Del Saz-Lara, Andrea
  • López de Las Hazas, María-Carmen
  • Tomé-Carneiro, Joao
  • Ávila-Gálvez, Maria-Ángeles
  • Crespo, María Carmen
  • Mazarío-Gárgoles, Carmen
  • Chapado, Luis A
  • Daimiel, Lidia
  • Visioli, Francesco
  • Martín-Santiago, Victoria
  • Espín de Gea, Juan Carlos
  • Dávalos, Alberto
Hydroxytyrosol (HT) consumption is associated with healthy outcomes. Specifically, its ability to modulate microRNA (miRNA) expression has been described. However, whether HT influences the secretion of extracellular vesicles (EVs) and their transported miRNAs remains unknown. Here, following HT administration, we explored the potential changes in EV secretion and in their miRNA cargo during postprandial state and after 1 week of daily intake. Twelve healthy participants received, first, a single 25 mg dose of HT (postprandial study) and then 25 mg HT daily, for one week (sustained study). Plasma and circulating plasma-isolated EVs were analyzed for HT and derived metabolites using UPLC-qTOF-MS and miRNAs by RNA-seq. HT induced the secretion of EVs 1-h post-ingestion and a 1-week daily administration of HT increased fasting EVs and reduced circulating oxidized LDL levels. RNA-seq analysis identified 55 modulated miRNAs (30 upregulated and 25 downregulated) related to response to oxygen level and gland development, following 1-week HT supplementation. This pilot study sheds light on the effects of HT consumption on EV secretion and modulation of exosomal miRNAs in humans, which has been scarcely studied to date. Further research is warranted to elucidate the molecular mechanisms underlying the observed effects., This research was funded by MCIN/ AEI /10.13039/501100011033 through the European and ERDF - “A way of making Europe” (PID2022-143100OB-I00 and PID2021-125899OB-I00), by the European Union NextGenerationEU/ PRTR (TED2021-130962B-C21 and TED2021-130962B-C22), by Comunidad de Madrid EXOHEP2-CM (S2022/BMD-7409), and by the AGROALNEXT program (MICIU, PRTR-C17.I1, Spain) with funding from the European Union NextGenerationEU (PRTR-C17.I1) and Fundación Séneca (Comunidad Autónoma Región de Murcia, Spain). M.C.L.H. is a recipient of a Ramon y Cajal Grant RYC2022-037626-I. C.M.-G. and L.B. are supported by a contract derived from Union NextGenerationEU/PRTR (TED2021-130962B-C21). A.S.-L. is supported by a predoctoral fellowship (N° 2021-01- PhD GRANT) from the International Olive Council. CIBEROBN (CB22/03/00068) is an initiative of the Instituto de Salud Carlos III, Spain. F.V. is partially funded by PRIN-2022 Prot. 2022NZNZH8., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Oral Delivery of Ellagic Acid Encapsulated in Milk Exosomes: Sex-Based Differences in Bioavailability, Urolithin Production, and Gut Microbiota Modulation

  • Ávila-Gálvez, María Ángeles
  • Romo-Vaquero, María
  • Mazarío-Gárgoles, Carmen
  • Tomé-Carneiro, Joao
  • López de Las Hazas, María-Carmen
  • Dávalos, Alberto
  • Selma, María Victoria
  • González-Sarrías, Antonio
  • Espín de Gea, Juan Carlos
Milk exosomes (EXOs) enhance polyphenols' bioavailability, but their potential for oral administration remains underexplored. Ellagic acid (EA) is poorly bioavailable. We investigate whether EA encapsulated in EXOs (EXO-EA) consumed orally improves EA bioavailability and (or) modulates gut microbiota. For 2 weeks, BALB/c mice received EXO, non-encapsulated EA (NEA), or EXO-EA (0.27 mg EA/kg bw) orally. Targeted and untargeted metabolomics (UPLC-qTOF-MS), fecal SCFAs (GC-MS), and gut microbiota (PacBio 16S-sequencing) were performed. Additionally, EA plasma and brain kinetics were evaluated in rats following intravenous administration of EXO-EA and NEA. Unlike NEA, EXO-EA quadrupled EA plasma levels in Sprague-Dawley rats and enabled brain detection. However, oral EXO-EA in mice failed to deliver EA systemically due to gastrointestinal instability, confirmed by in vitro digestion. Sex-dependent EXO-EA metabolomic effects were observed. Also, in males only, EXO-EA increased fecal urolithin A and SCFAs and enriched the microbiota with Christensenellaceae R7, Ruminococcus species, and Clostridium fusiformis, among others. In females, both EXO-EA and NEA enriched the microbiota with bifidobacteria, including Bifidobacterium pseudolongum. Oral EXO-EA impacted plasma metabolome, modulated gut microbiota, and increased urolithin A and SCFA production sex-dependently. However, gastrointestinal instability, limited EA encapsulation, and low dose administered prevented systemic delivery., This study was supported by Ministerio de Ciencia, Innovación y Universidades AGROALNEXT (PRTR-C17.I1), PID2022-136419OB-100, RYC2022-037626-I, TED2021-130962B-C21, and TED2021-130962B-C22, Fundación Séneca 22030/PI/22, AGROALNEXT (co-funding PRTR-C17.I1), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Microplastics and nanoplastics in the human intestine: A review of health implications and possible dietary interventions

  • Dávalos, Alberto
  • Martín-Santiago, Victoria
  • López de las Hazas, María-Carmen
Microplastics and nanoplastics (MNPs) have emerged as pervasive dietary contaminants, yet their implications for human health remain poorly defined. This review synthesized current evidence on MNP interactions with the gastrointestinal system, emphasizing barrier disruption, biotransformation, particle uptake, and gut microbiota dysbiosis. Experimental data indicate that particle size, polymer type, and surface properties critically influence intestinal uptake and toxicity, with smaller particles showing greater systemic translocation. Although human evidence is limited and methodologies lack standardization, preliminary associations link MNP exposure with inflammatory bowel disease and metabolic disturbances. Beyond risks, we highlight the role of dietary patterns in modulating exposure and effects: minimizing processed, packaged foods and enhancing fiber, antioxidants, and probiotics may reduce intestinal burden and mitigate oxidative and inflammatory responses. Bridging mechanistic insights with dietary strategies, this review underscores the urgent need for standardized detection methods, human cohort studies, and sustainable food-system interventions., This research was funded by MCIN/AEI/10.13039/501100011033 through the European and ERDF A way of making Europe (PID2023-150666OA-I00), by the Ramon Areces foundation (CIVP21S13273), and by Comunidad de Madrid EXOHEP2-CM (S2022/ BMD-7409). M-CLdlH is a recipient of a Ramon y Cajal Grant RYC2022-037626-I. VM-S is supported by a predoctoral fellowship from Comunidad de Madrid (PIPF-2023/SAL-GL-30783). CIBEROBN (CB22/03/ 00068) is an initiative of the Instituto de Salud Carlos III, Spain., Peer reviewed